Why SARS-CoV-2 replicates better in the upper respiratory tract

PTSD and harmful drinking in the UK Armed Forces and UK Police Service
31 March 2021
Incidental findings on brain MRI common in children
31 March 2021

Why SARS-CoV-2 replicates better in the upper respiratory tract

A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular defense mechanisms in the respiratory tract. They have shown that natural temperature differences that exist in the upper and lower respiratory tract have a profound influence on SARS-CoV-2 replication and subsequent innate immune activation in human cells. The findings can help to develop antiviral drugs and preventive measures.

Comments are closed.